1. 1ST International High Level Multi-Stakeholders Meeting on Promoting Pharmaceutical Sector Investments in the East African Community (EAC) Region   NAIROBI -2ND – 4TH OCTOBER Dr. Stanley Sonoiya Principal Health Officer EAC Secretariat

2. 1. East African Community (EAC)
East African Community (EAC) is a regional intergovernmental organization of 6 Partner States with recent joining of S. Sudan in March 2016
Population: million (Mid 2014), S. Sudan not included
GDP (current market price): $147.5 billion (2015), S. Sudan not included
EAC Headquarters: Arusha, Tanzania
Regional cooperation on Health provided in the Treaty
Chapter 21 (Article 118) of the EAC Treaty entered into July 2000, provides for medicines regulation harmonization

3. Overview of EAC Pharmaceutical Industry
Nascent but vibrant pharmaceutical manufacturing industry
High cost of inputs – Raw materials & utilities
Local production meets
25% of demand in Kenya &
15% Tanzania,
10% in Uganda
< 1% in Rwanda & Burundi

4. Overview of Local Pharmaceutical Manufacturing in EAC
40 plants (see above)
2 plants with WHO Pre-Qualification (ARVs and anti malarials)
40% capacity utilization 24 1 8 6
Imports
75%
25%
Local production

5. EAC Pharma. Technology Assessment : Which dosage forms are locally produced ?
Available
Not Available
Plain tablets
Ointments and creams
Sustained release tablets
Film coated tablets
Lotions and Suspensions (external)
Layered tablets
Hard capsules
Large volume injections (sterile)
Small volume injections (sterile)
Soft capsules
Ophthalmic formulations (sterile)
Sustained release capsules

6. EAC Pharma. Technology Assessment : Which dosage forms are locally produced ?
Available
Not Available
Powders
Ocular formulations (sterile)
Implants
Dry (granules) Suspension
Ocular formulations (non-sterile)
Sprays and inhalations
Suspensions (internal)
Vaccines
Medicated dressings
Syrups/Elixirs/Solutions (internal)
Diagnostic agents
Immune sera and immuno-globulins

7. Opportunities & Challenges in the regional market
Unmet demand
EAC Common market
Positive economic growth
High prevalence of both communicable and non-communicable diseases
Competition from low cost imports
Infrastructure
Quality standards
Human Resource
Appropriate financing
Support Industries

8. Enabling factors for Local Pharmaceutical Production in East Africa
Implementation of East African Community Pharmaceutical Manufacturing Plan : 2012 – 2016
Development of new plan EACRPMPOA : ongoing
Harmonization of Medicines Registration Process among the EAC Partner States – on-going.

9. Enabling factors for Local Pharmaceutical Production in East Africa
The pharmaceutical sector is among the six priority sectors in the EAC Industrialization strategy and policy.
Implementation of the Common Market Protocol
Strong private sector representation in EAC decision making process (Consultative Dialogue Framework)

10. Public health perspective of Promoting local production of Medicines
Ensures Sustainable of supply of essential medicines and better able to
respond to emergencies.
Better capacity to control counterfeit and
substandard medicines.
Improved capacity to find therapeutic solutions for diseases of public health concern in the region .

11. Industrial development perspective of Promoting local production of Medicines
Creation of employment opportunities especially highly skilled jobs
Savings of foreign exchange earnings
Technology Transfer and opportunities of joint ventures with foreign firms

12. 6.0 Overall goal is to achieve a balance
                                     
Access
Economic and industrial interests
Consumption
Market control
Public health
Appropriate utilization
Out come Protecting Your Rights To Quality Health Care